PAP
ROIV icon

Persistent Asset Partners’s Roivant Sciences ROIV Stock Holding History

Persistent Asset Partners’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.1K Hold
860
– – ﹤0.01% 286
2025
Q4 		$25.8K Buy
860
+169
+24% +$3.33K 0.01% 310
2025
Q3 		$36.3K Buy
+691
New +$8.55K 0.02% 191

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Persistent Asset Partners's ROIV Position: Q1 2026 in Review

Persistent Asset Partners sold out of Roivant Sciences (ROIV) in Q1 2026, closing a stake of 14,121 shares — an estimated $363K sold.

Persistent Asset Partners first reported a position in ROIV in Q3 2025 and held it in 2 quarters. The position peaked at $419K in Q3 2025. 439 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Persistent Asset Partners reported no remaining Roivant Sciences position as of Q1 2026 after selling out during the quarter.
  • Persistent Asset Partners sold 14,121 Roivant Sciences shares in Q1 2026, an estimated $363K.
  • Persistent Asset Partners first reported a position in Roivant Sciences in Q3 2025 and held it in 2 quarters.
  • Persistent Asset Partners's Roivant Sciences position peaked at $419K in Q3 2025.
  • 439 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.